120 related articles for article (PubMed ID: 28197637)
1. Inhibition of FASN suppresses migration, invasion and growth in hepatoma carcinoma cells by deregulating the HIF-1α/IGFBP1 pathway.
Gong J; Shen S; Yang Y; Qin S; Huang L; Zhang H; Chen L; Chen Y; Li S; She S; Yang M; Ren H; Hu H
Int J Oncol; 2017 Mar; 50(3):883-892. PubMed ID: 28197637
[TBL] [Abstract][Full Text] [Related]
2. RNAi Knockdown of Hypoxia-Inducible Factor-1α Decreased the Proliferation, Migration, and Invasion of Hypoxic Hepatocellular Carcinoma Cells.
Chen C; Liu R; Wang J; Yan Z; Qian S; Zhang W
Cell Biochem Biophys; 2015 Apr; 71(3):1677-84. PubMed ID: 25388848
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathway.
Zhang W; Huang J; Tang Y; Yang Y; Hu H
Ann Hepatol; 2020; 19(4):411-416. PubMed ID: 32536483
[TBL] [Abstract][Full Text] [Related]
4. [Fatty acid synthase interacts with signal transducer and activator of transcription 3 to promote migration and invasion in liver cancer cells].
Huang J; Zou XQ; She S; Shu F; Tuo H; Ren H; Hu HD; Yang YX
Zhonghua Gan Zang Bing Za Zhi; 2019 Sep; 27(9):681-686. PubMed ID: 31594092
[No Abstract] [Full Text] [Related]
5. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-1207-5p inhibits hepatocellular carcinoma cell growth and invasion through the fatty acid synthase-mediated Akt/mTOR signalling pathway.
Zhao G; Dong L; Shi H; Li H; Lu X; Guo X; Wang J
Oncol Rep; 2016 Sep; 36(3):1709-16. PubMed ID: 27461404
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 5 promotes the migration and invasion of hepatocellular carcinoma via increasing the transcription of hypoxia-inducible factor-1α under hypoxia condition.
Ye M; Fang Z; Gu H; Song R; Ye J; Li H; Wu Z; Zhou S; Li P; Cai X; Ding X; Yu S
Tumour Biol; 2017 Jun; 39(6):1010428317705034. PubMed ID: 28653891
[TBL] [Abstract][Full Text] [Related]
8. Effects of TMEM9 gene on cell progression in hepatocellular carcinoma by RNA interference.
Zhang Y; Ran Y; Xiong Y; Zhong ZB; Wang ZH; Fan XL; Ye QF
Oncol Rep; 2016 Jul; 36(1):299-305. PubMed ID: 27220462
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib blocks the HIF-1α/VEGFA pathway, inhibits tumor invasion, and induces apoptosis in hepatoma cells.
Xu M; Zheng YL; Xie XY; Liang JY; Pan FS; Zheng SG; Lü MD
DNA Cell Biol; 2014 May; 33(5):275-81. PubMed ID: 24611881
[TBL] [Abstract][Full Text] [Related]
10. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
11. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CD9 expression reduces the metastatic capacity of human hepatocellular carcinoma cell line MHCC97-H.
Lin Q; Peng S; Yang Y
Int J Oncol; 2018 Jul; 53(1):266-274. PubMed ID: 29749468
[TBL] [Abstract][Full Text] [Related]
13. HIF-2α attenuates lymphangiogenesis by up-regulating IGFBP1 in hepatocellular carcinoma.
Geis T; Popp R; Hu J; Fleming I; Henke N; Dehne N; Brüne B
Biol Cell; 2015 Jun; 107(6):175-88. PubMed ID: 25757011
[TBL] [Abstract][Full Text] [Related]
14. iTRAQ-based proteomic analysis of the molecular mechanisms and downstream effects of fatty acid synthase in osteosarcoma cells.
Fu D; Liu S; Liu J; Chen W; Long X; Chen X; Zhou Y; Zheng Y; Huang S
J Clin Lab Anal; 2021 Mar; 35(3):e23653. PubMed ID: 33405298
[TBL] [Abstract][Full Text] [Related]
15. AQP9 suppresses hepatocellular carcinoma cell invasion through inhibition of hypoxia-inducible factor 1α expression under hypoxia.
Qian Y; Liu F; Zhang W; Zheng X; Liao S; Lv L; Mei Z
J Gastroenterol Hepatol; 2020 Nov; 35(11):1990-1997. PubMed ID: 32115773
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Migration and Invasion of Hepatocarcinoma HepG2 Cells by Dietary Saponins via Targeting HIF-1α.
Luo C; Wu D; Chen M; Miao W; Xue C; Sun Y; Liu D; Xie C; Wang Y; Frenz C; Deng S
Anticancer Agents Med Chem; 2018; 18(7):1025-1031. PubMed ID: 29318977
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.
Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T
Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852
[TBL] [Abstract][Full Text] [Related]
18. Expression and roles of fatty acid synthase in hepatocellular carcinoma.
Hao Q; Li T; Zhang X; Gao P; Qiao P; Li S; Geng Z
Oncol Rep; 2014 Dec; 32(6):2471-6. PubMed ID: 25231933
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of fatty acid synthase suppresses neovascularization via regulating the expression of VEGF-A in glioma.
Zhou Y; Jin G; Mi R; Zhang J; Zhang J; Xu H; Cheng S; Zhang Y; Song W; Liu F
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2447-2459. PubMed ID: 27601165
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia suppresses E-cadherin and enhances matrix metalloproteinase-2 expression favoring esophageal carcinoma migration and invasion via hypoxia inducible factor-1 alpha activation.
Jing SW; Wang YD; Chen LQ; Sang MX; Zheng MM; Sun GG; Liu Q; Cheng YJ; Yang CR
Dis Esophagus; 2013 Jan; 26(1):75-83. PubMed ID: 22340517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
